Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 63.09
(-3.68%)
CNY 63.09
(-3.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.29 Billion CNY | 34.0% |
| 2022 | -1.96 Billion CNY | 8.49% |
| 2021 | -2.14 Billion CNY | -661.69% |
| 2020 | -281.21 Million CNY | -344.58% |
| 2019 | -63.25 Million CNY | -429.61% |
| 2018 | -11.94 Million CNY | 72.39% |
| 2017 | -43.26 Million CNY | -446.97% |
| 2016 | -7.9 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.19 Billion CNY | -23.66% |
| 2024 Q1 | -1.21 Billion CNY | 5.75% |
| 2024 Q2 | -967.62 Million CNY | 20.64% |
| 2023 Q3 | -1.37 Billion CNY | 19.65% |
| 2023 FY | -1.29 Billion CNY | 34.0% |
| 2023 Q4 | -1.29 Billion CNY | 6.19% |
| 2023 Q2 | -1.71 Billion CNY | 8.01% |
| 2023 Q1 | -1.86 Billion CNY | 4.82% |
| 2022 FY | -1.96 Billion CNY | 8.49% |
| 2022 Q3 | -1.88 Billion CNY | 13.56% |
| 2022 Q4 | -1.96 Billion CNY | -3.79% |
| 2022 Q2 | -2.18 Billion CNY | 27.4% |
| 2022 Q1 | -3 Billion CNY | -40.48% |
| 2021 Q2 | -1.96 Billion CNY | 3.34% |
| 2021 FY | -2.14 Billion CNY | -661.69% |
| 2021 Q1 | -2.03 Billion CNY | -612.54% |
| 2021 Q4 | -2.14 Billion CNY | -21.05% |
| 2021 Q3 | -1.76 Billion CNY | 10.06% |
| 2020 Q3 | -120.22 Million CNY | 3.77% |
| 2020 Q2 | -124.94 Million CNY | -199.75% |
| 2020 Q1 | 125.25 Million CNY | 298.02% |
| 2020 FY | -281.21 Million CNY | -344.58% |
| 2020 Q4 | -285.63 Million CNY | -137.58% |
| 2019 Q4 | -63.25 Million CNY | 0.0% |
| 2019 FY | -63.25 Million CNY | -429.61% |
| 2018 FY | -11.94 Million CNY | 72.39% |
| 2017 FY | -43.26 Million CNY | -446.97% |
| 2016 FY | -7.9 Million CNY | 0.0% |